If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 4 Similar Profiles
Cost-Benefit Analysis Medicine & Life Sciences
Bovine Tuberculosis Medicine & Life Sciences
Infection Medicine & Life Sciences
Calibration Medicine & Life Sciences
Quality-Adjusted Life Years Medicine & Life Sciences
HIV Medicine & Life Sciences
Chlamydia Medicine & Life Sciences
bovine tuberculosis Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2020

Research Output 2004 2019

Dynamics of drug resistance: Optimal control of an infectious disease

Chehrazi, N., Cipriano, L. E. & Enns, E., Jan 1 2019, In : Operations research. 67, 3, p. 619-650 32 p.

Research output: Contribution to journalArticle

Public health
Infectious diseases
Optimal control

HIV Care Trajectories as a Novel Longitudinal Assessment of Retention in Care

Enns, E., Reilly, C. S., Horvath, K. J., Baker-James, K. & Henry, K., Jan 1 2019, In : AIDS and Behavior.

Research output: Contribution to journalArticle

Public Hospitals
Viral Load
Medical Records

“Time Traveling Is Just Too Dangerous” but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier

Alarid Escudero, F., Enns, E., Kuntz, K. M., Michaud, T. L. & Jalal, H., May 1 2019, In : Value in Health. 22, 5, p. 611-618 8 p.

Research output: Contribution to journalArticle

Cost-Benefit Analysis
Cerebrospinal Fluid
Helicobacter pylori
1 Citation (Scopus)

Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance

Lee, K., Drekonja, D. M. & Enns, E., Mar 1 2018, In : Value in Health. 21, 3, p. 310-317 8 p.

Research output: Contribution to journalArticle

Quality-Adjusted Life Years
Antibiotic Prophylaxis
Cost-Benefit Analysis